An international survey of classification and treatment choices for group D retinoblastoma

Tarih
2017
Yazar
YAROVOY, Andrey
Pe'er, Jacob
MUNIER, Francis
BERRY, Jesse
HARBOUR, J. William
LUCENA, Evandro
MURRAY, Timothy G.
BHAGIA, Pooja
PAYSSE, Evelyn
CHANTADA, Guillermo L.
Moll, Annette C.
USHAKOVA, Tatiana
Plager, David A.
ZIYOVUDDIN, Islamov
LEAL, Carlos A.
MATERIN, Miguel A.
JI, Xun-Da
CURSINO, Jose W.
POLANIA, Rodrigo
Kiratli, Hayyam
ALL-ERICSSON, Charlotta
HONAVAR, Santosh G.
VISHNEVSKIA-DAI, Vicktoria
EPELMAN, Sidnel
Daniels, Anthony B.
Ling, Jeanie D.
TRAORE, Fousseyni
RAMIREZ-ORTIZ, Marco A.
Kebudi, Rejin
Tuncer, Samuray
SCELFO, Christina
FRANCIS, Jasmine H.
KHETAN, Vikas
JENKINS, Thomas
MARR, Brian
ABRAMSON, David H.
SHIELDS, Carol L.
Üst veri
Tüm öğe kaydını göster
Özet
AIM: To determine which IIRC scheme was used by retinoblastoma centers worldwide and the percentage of D eyes treated primarily with enucleation versus globe salvaging therapies as well as to correlate trends in treatment choice to IIRC version used and geographic region.
Bağlantı
http://hdl.handle.net/20.500.12627/61822
https://doi.org/10.18240/ijo.2017.06.20
Koleksiyonlar